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Abstracts / Osteoarthritis and Cartilage 21 (2013) S63–S312 S251patients aged < 60 years. Patients aged  60 years showed improved
WOMAC Total score for continuous vs intermittent treatment, but
statistical signiﬁcance was not attained. These data may be useful for
health care providers in considering the treatment of OA patients.
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SERUM URIC ACID AS A PREDISPOSING FACTOR OF CLINICO-
RADIOLOGICAL SEVERITY OF OSTEOARTHRITIS KNEE
R.N. Srivastava, D. Sanghi, A. Mishra, A. Sharma, S. Raj, S. Natu. KG Med.
Univ., Lucknow, India
Purpose: Osteoarthritis (OA) is the most common arthritis worldwide.
The association with age, obesity, gender and metabolic factors has
been studied widely. Evidence suggests that hyperuricemia is signiﬁ-
cantly associated with OA of multiple joints. The high level of uric acid
involved in cartilage degeneration may modulate radiological features
of knee OA. Some study reported that uric acid is associated with
generalized OA and other reported that it is a danger signal of increasing
risk for OA through inﬂammasome activation and concluded that
synovial uric acid is a marker of knee OA severity. Both OA and hyper-
uricemia are common in India. This study aimed to investigate the
association of serum uric acid with clinico-radiological feature of knee
OA in Indian population.
Methods: 180 patients of OA knee diagnosed according to American
College of Rheumatology (ACR) guidelines as cases and equal number of
controls were enrolled. Clinical OA outcome: pain, stiffness and func-
tional disability were recorded by knee-speciﬁc WOMAC index and
knee pain was also measured by 10 point VAS. Radiological grading was
done by KL grades. In addition, four individual radiological features
(IRF)- joint space width, osteophyte, subchondral sclerosis and tibio
femoral alignment were also recorded separately. Demographic were
recorded by self report. Serum uric acid levels were measured by
enzymatic method using Uricase - Peroxidase and analyzed for the
interlinking associations.
Results: OA knee cases had signiﬁcant higher BMI than controls in
overall and in both the genders separately. In females, serum uric acid
levels were signiﬁcantly higher in cases in comparison to controls but
such association was not observed in males and in overall subjects.
Other biochemical variable like random blood sugar and total proteins
were not signiﬁcantly different between cases and controls in any
category.
On analyzing serum uric acid level with clinical features, pain (VAS and
WOMAC) was signiﬁcantly associated (p¼0.02 and p¼0.03) with
elevated serum uric acid levels in females; VAS pain alone in overall
study population (p¼0.024) but not in males. While studying the
radiological features, an increase severity of disease (increasing KL
grades) was observed with increase in serum uric acid levels (KL grade 4
was 5.26  1.1, KL grade 3 was 4.32  0 .95 and KL grade 2 was 3.63 
0.95) in overall subjects and in both the genders separately. No signif-
icant association was observed for individual radiological features (IRF).
Conclusion: Radiological severity (KL grade) and knee pain was found
to be signiﬁcantly associated with serum uric acid levels in overall
subjects and in females in OA knee.
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PLASMA ADIPOKINES AS MEDIATORS IN EARLY KNEE
OSTEOARTHRITIS: DATA FROM COHORT HIP AND COHORT KNEE
(CHECK)
W.E. van Spil, P.M. Welsing, M.B. Kinds, S.C. Mastbergen, J.W.
Bijlsma, F.P. Lafeber. Univ. Med. Ctr. Utrecht, Utrecht, The Netherlands
Purpose: Associations of body mass index (BMI) with hand osteoar-
thritis (OA) have suggested that humoral obesity-related factors may be
involved in the pathogenesis of OA. Systemic adipokine levels depend
on BMI (amount of fat), gender (different fat distribution between
genders), and to a lesser extent age. The purpose of the current study
was to determine whether plasma adipokines could be identiﬁed as
potential mediators of associations of BMI and other demographic
variables with radiographic knee parameters in CHECK (Cohort Hip and
Cohort Knee), a cohort of (very) early-stage symptomatic knee and/or
hip osteoarthritis (OA).
Methods: Plasma (p-) leptin, adiponectin, and resistin levels were
determined by enzyme-linked immunosorbent assay. Joint space width
(JSW; minimum, mean medial, and mean lateral), osteophyte (OP) area,and subchondral bone density (BD) were quantiﬁed in detail on post-
eroanterior knee radiographs using Knee Image Digital Analysis (KIDA).
Mediation analysis was performed to determine whether indirect
associations through adipokines could explain (part of the) associations
of BMI and other demographic variables with radiographic knee
parameters.
Results: Adipokine and radiographic data were complete for
approximately 430 CHECK subjects with knee pain. pLeptin was
identiﬁed as potential mediator of associations of BMI and female
gender with JSW. Likewise, pResistin was a potential mediator of an
association of BMI with JSW. None of the adipokines could be
identiﬁed as potential mediators between demographic variables and
OP area. pAdiponectin appeared to be a potential mediator of asso-
ciations of BMI and female gender with subchondral BD. Although
statistically signiﬁcant, associations of demographic variables and
adipokines with radiographic knee parameters were weak and adi-
pokines could explain only part of the associations between demo-
graphic variables and knee parameters.
Conclusions: Systemic adipokines might be mediators of associations
of BMI and gender with JSW and subchondral BD. As such, although
their rolemight be limited, theymay play a role in the etiology of (knee)
OA.479
THE ASSOCIATION BETWEEN KNEE FUNCTION AND RADIOGRAPHIC
OSTEOARTHRITIS IN A POPULATION BASED COHORT - THE
MUSCULOSKELETAL ULLENSAKER STUDY
B. Øiestad y,z, C. Nørstad Engen x, M. Risberg k,y. yNorwegian research
centre for Active Rehabilitation, Oslo, Norway; zOslo Univ. Hosp., Oslo,
Norway; xOslo Sports Trauma Research Ctr., Oslo, Norway; kNorwegian
Sch. of Sport Sci., Oslo, Norway
Purpose: The objective of this study was to investigate the association
between radiographic knee osteoarthritis and knee function evaluated
by both self-reported questionnaires and performance based tests.
Methods: The Musculoskeletal Ullensaker study (MUST) is an ongoing
population-based study of musculoskeletal disorders performed in
Ullensaker municipality representing the Norwegian population. Invi-
tation letters were sent to all the inhabitants between 40 and 79 years
(n¼12000), and those who self-reported either hand, knee, or hip
osteoarthritis, veriﬁed by their general practitioner, were invited to
a clinical examination including functional, clinical, and radiographic
measures of the three joints. Standing radiographs using SynaFlexer
frame for standardized positioning were taken of all the invited
participants and scored with the Kellgren and Lawrence atlas (grade
0-4). Osteoarthritis was deﬁned as KL  grade 2. Knee injury and
Osteoarthritis Outcome Score (KOOS) was used for measuring pain,
symptoms, and activities of daily living (ADL), function in sport and
recreation (sport/rec), and knee-related quality of life (QOL). The
30-second Chair Stand test and 6 min-walk test were included to
measure performance based function. Multivariate regression analyses
with each KOOS subscale and the performance based tests as dependent
variable were associated with radiographic osteoarthritis in one knee,
adjusted for gender, age, and body mass index (BMI).
Results: Three hundred and twenty three patients were examined
between 2010 and 2012 (31% males and 69% females). The mean age
was 63.58.8 years. Knee osteoarthritis was found in 8.7% for the right
knee (n¼28), in 6.8 % for the left knee (n¼22), and 34 patients (10.5%)
had osteoarthritis in both knee joints. Two hundred and twenty seven
patients (70%) had no radiographic knee osteoarthritis. Signiﬁcant
associations were found between radiographic osteoarthritis in one
knee and the following KOOS subscales: pain (BetaSE: -13.73.7,
p<0.000), other symptoms (-13.13.1, p<0.000), ADL (-9.43.5,
p<0.000), sport/rec (-22.75.7, p<0.000) and QOL (-21.44.6,
p<0.000) compared to those without osteoarthritis. No signiﬁcant
associations were found between the 30-second Chair Stand test and 6
min walk test and radiographic osteoarthritis, respectively.
Conclusion: Radiographic knee osteoarthritis was highly signiﬁ-
cantly associated with poorer self-reported knee function compared
to those without radiographic knee osteoarthritis; clinical signiﬁ-
cant differences were disclosed for all KOOS subscales ranging from
9 to 22 points. However, there was no signiﬁcant association
between radiographic knee osteoarthritis and performance based
function.
Abstracts / Osteoarthritis and Cartilage 21 (2013) S63–S312S252Figure 1. Presentation of the mean values of the KOOS subscales for different grades of
radiographic changes in the right knee joint (n¼302). Normative values are age
matched values from Paradowski et al. 2006.
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IMPACT OF PREDICTABLE VERSUS UNPREDICTABLE INTERMITTENT
PAIN ON SOCIAL ROLE PARTICIPATION IN SUBJECTS WITH KNEE
OSTEOARTHRITIS
T. Kendzerska y,z, M. Gignac y,x, I. Stanaitis z, G. Hawker y,z. yUniv. of
Toronto, Toronto, ON, Canada; zWomen's Coll. Hosp., Toronto, ON,
Canada; x Toronto Western Res. Inst., Toronto, ON, Canada
Purpose: Focus group discussions in individuals with hip/knee osteo-
arthritis (OA) identiﬁed two types of OA pain - a constant background
pain and a less frequent, but more intense and often unpredictable,
intermittent pain - with the latter having the greatest impact on social
role participation. These ﬁndings led to the creation of the OARSI-
OMERACT measure of Intermittent and Constant OA Pain (ICOAP). The
current study sought to validate focus group ﬁndings with respect to the
inﬂuence of OA pain predictability on participation restrictions.
Methods: In an established community cohort aged 50+ years with hip/
knee OA, we assessed demographic characteristics, OA pain (ICOAP
Knee) and disability (KOOS-PS), and participation restrictions. ICOAP is
comprised of two subscales: a 5-item scale assesses constant pain and
a 6-item scale assesses intermittent pain, or ‘pain that comes and goes’.
Subscale scores are created by summing item scores and transforming
to 0-100; higher scores indicate greater pain. Those with intermittent
pain were asked to report the frequency with which the pain occurs
‘without warning’ (i.e., unpredictably) and ‘after a trigger’ (i.e.,
predictably), from 0 (never) to 4 (very often). To assess social role
participation, participants were asked the degree to which they had
given up or limited time spent in important roles due to their hip/knee
arthritis, from 1, not at all, to 5, a great deal. Logistic regressionwas used
to examine the effect of the frequent unpredictable and frequent
predictable intermittent knee pain (often/very often - yes/no) on
participation restrictions (roles restricted quite a bit/a great deal - yes/
no), controlling for age, gender, and OA severity (ICOAP subscale scores;
KOOS-PS score). Speciﬁcally, we assessed for interactions between
ICOAP intermittent scores and each of frequent unpredictable and
predictable knee pain on social role restrictions.
Results: 265 cohort participants with complete datawere included in our
analyses. Theirmean agewas 65 years (SD 10) and 75%were female. 69.6%
reported intermittent knee pain only, 22.5% constant knee pain only, and
7.9%bothpain types.Median (IQR) ICOAP intermittent and constant scores
were 37.5 (20.8-45.8) and 0 (0), respectively. Of the 186 subjects who re-
ported intermittent pain, 14.6% reported frequent unpredictable pain and
10.9% reported frequent predictable pain. 40% and 36.6% had limited time
spent in ‘important roles’ ‘somewhat’ or ‘quite a bit’. Controlling for age,
sex, ICOAPsubscale andKOOS-PS scores,we found a signiﬁcant interaction
between ICOAP intermittent pain severity and frequency of unpredictable
pain on participation restrictions (p¼0.03), such that for individuals with
similar levels of intermittent pain severity, the impact on social role
participationwasgreater for thosewithmore frequent versus less frequent
unpredictable intermittent pain. No interaction was found between
intermittent pain severity and frequent predictable pain.
Conclusion: Our results conﬁrm ﬁndings from qualitative research that,
controlling for other factors, social role restrictions are greatest among
those with intermittent knee pain that frequently occurs warning
inﬂuences. Further studies in larger cohorts, and with greater variability
in pain types, is warranted to conﬁrm our ﬁndings and, if conﬁrmed, to
elucidate potential explanations.481
EFFICACY AND TOLERABILITY OF CELECOXIB AND NAPROXEN VS
PLACEBO IN HISPANIC PATIENTS WITH KNEE OSTEOARTHRITIS
M.N. Essex, R. Behar, M.A. O'Connell, P. Bhadra Brown. Pﬁzer Inc., New
York, NY, USA
Purpose: The primary objective of this study was to determine if cel-
ecoxib 200 mg once daily (qd) was as effective as naproxen 500 mg
twice daily (bid) in the treatment of osteoarthritis (OA) of the knee in
Hispanic patients.
Methods: Hispanic patients aged 45 years with diagnosed knee OA in
a ﬂare state and with a functional capacity classiﬁcation of I to III were
randomized in a 2:2:1 manner to receive celecoxib 200 mg qd, nap-
roxen 500 mg bid, or placebo for 6 weeks. The primary efﬁcacy variable
was the change in the Patient's Assessment of Arthritis Pain at 6 weeks
compared with baseline. Secondary efﬁcacy variables were change in
Patient's and Physician's Global Assessments of Arthritis from baseline
to Week 6/early termination, change in Western Ontario and McMaster
Universities Osteoarthritis Index (WOMAC) scores from baseline to
Week 6/early termination, change in American Pain Society pain scores,
score on Pain Satisfaction Scale, Patient Health Questionnaire (PHQ-9)
responses, and measurement of upper GI (UGI) tolerability.
Results: 318 subjects were randomized; 239 completed the trial (96
celecoxib, 96 naproxen, 47 placebo) and formed the primary analysis
population. Celecoxib was observed to be as effective as naproxen in
reducing OA pain (least squares mean change from baseline -39.7,
standard error [SE] 2.7 for celecoxib, -36.9, SE 2.6 for naproxen; the
lower bound of the 2-sided 95% conﬁdence interval for the treatment
difference [naproxen-celecoxib] was above -10 mm). Similar efﬁcacy
was seen for celecoxib and naproxen in secondary outcomes. No
statistically signiﬁcant differences between celecoxib and naproxen
groups were seen on the Patient's or Physician's Global Assessments of
Arthritis, WOMAC Index scores, UGI, Pain Satisfaction Scale score, and
PHQ-9. The incidence of adverse events (AE) and treatment-related AEs
was similar among treatment groups. 13 subjects withdrew from the
study due to AEs (3 celecoxib, 9 naproxen, 1 placebo); 10 discontinued
due to treatment-related AEs (2 celecoxib, 7 naproxen, 1 placebo). UGI
events (moderate or severe nausea, abdominal pain, and/or dyspepsia)
were reported by 3 celecoxib, 4 naproxen, and 1 placebo subject. One
subject in the naproxen group had a GI hemorrhage; this was consid-
ered a treatment-related AE and resulted in withdrawal from the study.
Conclusions: Celecoxib 200 mg qdwas as effective as naproxen 500mg
bid in the treatment of signs and symptoms of knee OA in Hispanic
subjects. Celecoxibwas shown to be safe andwell tolerated in this study
population. This information may be of use to physicians treating
Hispanic patients with OA.482
RESPONSE TO NONSTEROIDAL ANTI-INFLAMMATORY AGENTS IN
ASIAN PATIENTS WITH OSTEOARTHRITIS OF THE KNEE
M.N. Essex, M.A. O'Connell, R. Behar, P. Bhadra Brown. Pﬁzer Inc, New
York, NY, USA
Purpose: Celecoxib is an effective treatment for osteoarthritis (OA);
however, its efﬁcacy and safety proﬁle has not been extensively studied
in different ethnic populations. Differences in therapeutic response to
pharmacologic agents have been found in the Asian population, but
there are limited data for OA treatments. This study was designed to
compare analgesic efﬁcacy, tolerability, and safety of celecoxib, nap-
roxen, and placebo in an Asian American population with OA of the
knee.
Methods: Eligible patients in this 6-week, multicenter, randomized,
double-blind, placebo-controlled, parallel-group study were aged  45
years, of self-reported Asian descent, and with OA of the knee in a ﬂare
state and a functional capacity classiﬁcation of I to III. Patients were
randomized to 1 of 3 regimens: celecoxib 200 mg once daily (qd),
naproxen 500 mg twice daily (bid), or placebo, in a 2:2:1 ratio. The
primary efﬁcacy variable was the change in the Patient's Assessment of
Arthritis Pain at Week 6 compared with baseline using a 100 mm visual
analog scale (VAS). Secondary efﬁcacy variables included Patient's and
Physician's Global Assessment of Arthritis, Western Ontario and
McMaster Universities Osteoarthritis Index (WOMAC), Pain Satisfaction
Scale, Patient Health Questionnaire (PHQ-9), and American Pain Society
(APS) pain scores. Other secondary variables included evaluations of
